AI-generated summary
The authors report a systematic review and meta-analysis of 22 randomised placebo-controlled trials (n=1063) of low-level laser therapy for knee osteoarthritis. They found that LLLT was associated with reduced pain and disability compared with placebo, with larger pain reductions at recommended doses, and no adverse events reported.
- Participants
- 1,063
- Studies included
- 22
- Who or what was studied
- Adults with knee osteoarthritis diagnosed by American College of Rheumatology and/or Kellgren/Lawrence criteria
- Wavelengths
- 785, 860, 904 nm
- Limits stated in the abstract
- The abstract does not state the certainty of evidence, and the authors note that LLLT is not recommended in major knee osteoarthritis guidelines.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on bmjopen.bmj.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 785-860 nm, 904 nm
- Total energy
- 8 J, 3 J
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Visual analogue scale, Placebo-controlled, Systematic review, Osteoarthritis, Meta-analysis, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.